Oligonucleotide-based therapies are reshaping cancer care through precise gene modulation and advanced delivery.
Discover the science shaping next-gen cancer therapeutics at OTDC-2026
🗓️ 25–26 May 2026 |📍 Rome, Italy
🔗 oligo-nucleotide.com

#OTDC2026 #CancerResearch #RNATherapeutics #DrugDelivery

🧬 From antitarget identification to genetics-driven discovery, RNA-based strategies are redefining antiviral drug development. These insights align with key discussions at OTDC.
📍Rome, Italy |🗓️ May 25–26, 2026
🔗 oligo-nucleotide.com
#RNAtherapeutics #PrecisionMedicine #GeneticMedicine #OTDC2026

🧬 Circulating microRNAs are transforming medicine as stable, non-invasive biomarkers for disease detection and therapeutic response.
Join the discussion on miRNA therapeutics & delivery at OTDC
🗓️ May 25–26, 2026 | 📍 Rome, Italy
🔗 oligo-nucleotide.com

#miRNA #RNAtherapeutics #OTDC2026 #DrugDelivery

Lipid nanoparticles are transforming precision cancer therapy with smarter, targeted delivery.
Join us at OTDC, May 25–26, 2026 in Rome, Italy, to explore next-gen oligonucleotide innovation.
🔗 oligo-nucleotide.com
#LNP #Nanomedicine #OTDC2026 #CancerTherapy#Nanocarriers #SmartDrugDelivery

Systemic delivery of oligonucleotide drugs remains a challenge from nuclease degradation and RES clearance to BBB obstruction and endosomal entrapment.
📢These exciting topics will be explored at OTDC-2026, happening May 25–26 in Rome,Italy.
🔗 oligo-nucleotide.com
#OTDC2026 #RNAtech #DrugDelivery